расширенный поиск

The role of genetic factors in levodopa-induced dyskinesias development in Russian patients with Parkinson's disease: A pilot study

Akhmadeeva, G., Khidiyatova, I., Gilyazova, I., Baitimerov, A., Magzhanov, R.

Publication date: 2019

DOI: 10.1016/j.jns.2019.10.289

Abstract:

Levodopa is the most effective drug for the treatment of Parkinson's disease (PD). After about 5 years, most patients develop severe side effects such as dyskinesias and motor fluctuations after levodopa therapy

Keywords:
Web of Science, Levodopa, Parkinson's disease (PD)

Издатель: ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Тип: Article



Google Scholar
OpenDoar

Фасеты

Оппонент
Научный руководитель
Авторы
Ключевые слова
Год